Disease Information & Support


The Word:


Generic name Decitabine
Pronunciation De-SIT-a-been
Brand name(s), other common name(s) Dacogen®
Drug type  Hypomethylating (Demethylating) agent
How the drug is given Intravenously (IV)

Decitabine is FDA approved to treat adults with myelodysplastic syndromes (MDS) or chronic myelomonocytic leukemia.

Side effects needing medical attention: Signs of an allergic reaction (hives, difficulty breathing, swelling of the face, lips, tongue or throat); fever, chills, body aches or other flulike symptoms; unusual bleeding or bruising; pale skin; unusual weakness; white patches or sores inside the mouth or on the lips; swelling in the hands, ankles or feet.


For information on how to manage the costs of drug therapy, please see Financial Matters and Prescription Drug Coverage, or to speak with an Information Specialist, call (800) 955-4572.

last updated on Monday, October 15, 2012